ICD-10-CM Code Z79.8

Other long term (current) drug therapy

Version 2020 Non-Billable Code

Not Valid for Submission

Z79.8 is a "header" nonspecific and non-billable code code, consider using a code with a higher level of specificity for a diagnosis of other long term (current) drug therapy. The code is NOT valid for the year 2020 for the submission of HIPAA-covered transactions.

ICD-10:Z79.8
Short Description:Other long term (current) drug therapy
Long Description:Other long term (current) drug therapy

Consider the following ICD-10 codes with a higher level of specificity:

  • Z79.81 - Long term (current) use of agents affecting estrogen receptors and estrogen levels
  • Z79.810 - Long term (current) use of selective estrogen receptor modulators (SERMs)
  • Z79.811 - Long term (current) use of aromatase inhibitors
  • Z79.818 - Long term (current) use of other agents affecting estrogen receptors and estrogen levels
  • Z79.82 - Long term (current) use of aspirin
  • Z79.83 - Long term (current) use of bisphosphonates
  • Z79.84 - Long term (current) use of oral hypoglycemic drugs
  • Z79.89 - Other long term (current) drug therapy
  • Z79.890 - Hormone replacement therapy
  • Z79.891 - Long term (current) use of opiate analgesic
  • Z79.899 - Other long term (current) drug therapy

Code Classification

  • Factors influencing health status and contact with health services (Z00–Z99)
    • Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)
      • Long term drug therapy (Z79) (current)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020